Skip to main content
OpenTrials

Clinical trial condition

Disease Attributes

Explore clinical trials studying Disease Attributes. Study availability and eligibility vary by location and protocol.

21,705 public trials 3,134 recruiting studies
Refine in advanced search Browse all conditions

Disease Attributes trial results

Recruiting

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

NCT07082803

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Stanford Medicine Cancer Center Palo Alto, California, United States
  • The START Center for Cancer Care - Midwest Grand Rapids, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 14 locations
View Trial Details
Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

NCT04588922

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations
  • O'Neal Comprehensive Cancer Center, University of Alabama Birmingham, Alabama, United States
  • City of Hope - Phoenix Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 32 locations
View Trial Details
Recruiting

A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany

NCT07549516

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Novartis Investigative Site Baden-Baden, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Heidenheim, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Schwäbisch Hall, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Aschaffenburg, Bavaria, Germany
View all 65 locations
View Trial Details
Recruiting

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

NCT07104032

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • HonorHealth Cancer Center Scottsdale, Arizona, United States
  • Providence Medical Foundation Fullerton, California, United States
  • UC Irvine Health Orange, California, United States
View all 33 locations
View Trial Details
Recruiting

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

NCT07723248

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • Urology Specialists of the Carolinas - University Place Charlotte, North Carolina, United States
  • Summit Urology Murray, Utah, United States
  • First Urology PSC Jeffersonville, Indiana, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
View Trial Details

Related conditions